| Product Name | NebuSelect™ Recombinant Human SEMA4B, His-tag |
|---|---|
| Catalog Number | NBL-242130 |
| Alias/Synonyms | SEMA4B; Semaphorin-4B; Semaphorin-C; SEMA4B; KIAA1745; SEMAC; MGC131831; SemC |
| Appearance | see COA |
| Molecule Weight | Leu44-Glu717 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q9NPR2 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242130-100ug | 100ug | Inquire | Inquire | |
| NBL-242130-1mg | 1mg | Inquire | Inquire | |
| NBL-242130-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human SEMA4B, His-tag
Catalog#:
NBL-242130
Description:
NebuSelect™ Recombinant Human SEMA4B, His-tag(Cat#NBL-242130) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu44-Glu717.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 75.8 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.
Target Name:
SEMA4B; Semaphorin-4B; Semaphorin-C; SEMA4B; KIAA1745; SEMAC; MGC131831; SemC
Target Information:
Semaphorin 4B (SEMA4B) inhibits the invasion of non-small cell lung cancer (NSCLC) through PI3K-dependent suppression of MMP9 activation. SEMA4B may induce FoxO1 nuclear retention through suppressing PI3K/Akt signaling pathway, which subsequently inhibited cell growth through the direct nuclear target of FoxO1, p21. A role of SEMA4B in suppressing NSCLC growth, besides its role in inhibiting cell metastasis, and highlights SEMA4B as a promising therapeutic target for NSCLC.
Amino Acid Sequence:
Leu44-Glu717
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.